Publications

Precision Medicine - Biomarkers & Diagnostics

Acobiom, recognized for its scientific expertise and technical know-how

The scientific team of Acobiom has been involved in 60 scientific peer-review publications in which its scientific expertise and its technical know-how in molecular biology (genomics, transcriptomics), bioinformatics, and biostatistics have been recognized.

Acobiom is and has been involved in several national and international research programs focused on the identification of new biomarkers, on the development of new diagnostics and innovative therapeutics.
Most of these researches, collaborations or partnerships have issued several scientific peer-review publications: Front Immunology, Plos One, Annals Oncology, BMC Genomics, Nucleic Acid Research, Genomics, Blood, Cancer Research, Haematologica, Oncogene…

Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform Expression.
 

Carlini F et al.
Front Immunol. 2017

Lipid Droplet Formation, Their Localization and Dynamics during Leishmania major Macrophage Infection.
 

Rabhi I et al.
PLoS One. 2016

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.

Deplanque G et al.
Ann Oncol. 2015

Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite.

Rabhi I et al.
BMC Genomics. 2013

MicroRNA expression profile in human macrophages in response to Leishmania major infection.
 

Lemaire J et Al.
PLoS Negl Trop Dis. 2013

MicroRNAs: new candidates for the regulation of the human cumulus-oocyte complex.
 

Assou S et al.
Hum Reprod. 2013

The intellectual disability of trisomy 21: differences in gene expression in a case series of patients with lower and higher IQ.

Mégarbané A et al.
Eur J Hum Genet. 2013

Of mice and men: divergence of gene expression patterns in kidney.
 
 

Cheval L et al.
PLoS One. 2012

New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.

Bou Samra E et al.
Br J Haematol. 2012